NCT05715333View on ClinicalTrials.gov

Study of CM326 Injection in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

October 4, 2023

Study Completion Date

October 4, 2023

Conditions
Healthy
Interventions
BIOLOGICAL

CM326

CM326 Injection

OTHER

Placebo

Subcutaneous injection

Trial Locations (1)

Unknown

PKUCare Luzhong Hospital, Zibo

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT05715333 - Study of CM326 Injection in Healthy Subjects | Biotech Hunter | Biotech Hunter